Privia Health Group (NASDAQ:PRVA) Now Covered by Macquarie

Macquarie assumed coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research note issued to investors on Monday morning, MarketBeat Ratings reports. The firm issued an outperform rating and a $25.00 price objective on the stock.

A number of other brokerages have also recently commented on PRVA. KeyCorp began coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Robert W. Baird upped their price target on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. JPMorgan Chase & Co. increased their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Barclays boosted their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Finally, Truist Financial raised their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $24.80.

Privia Health Group Stock Performance

NASDAQ PRVA opened at $21.87 on Monday. The business has a fifty day moving average price of $20.05 and a 200 day moving average price of $19.07. The company has a market cap of $2.62 billion, a P/E ratio of 218.72, a P/E/G ratio of 5.45 and a beta of 0.83. Privia Health Group has a one year low of $15.92 and a one year high of $24.30.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC increased its stake in Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after buying an additional 930 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of Privia Health Group by 2.6% during the 2nd quarter. Louisiana State Employees Retirement System now owns 52,200 shares of the company’s stock worth $907,000 after purchasing an additional 1,300 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Privia Health Group by 8.8% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 9,758 shares of the company’s stock valued at $170,000 after purchasing an additional 788 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Privia Health Group by 7.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,742 shares of the company’s stock valued at $413,000 after purchasing an additional 1,653 shares during the period. Finally, Peregrine Capital Management LLC boosted its holdings in Privia Health Group by 11.5% during the second quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock worth $5,461,000 after buying an additional 32,311 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.